Search results

594 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Physician trust, early screening reduces disparities for prostate cancer
Men who have a regular, ongoing relationship with a health care provider are more likely to receive prostate cancer screening and less likely to be diagnosed with advanced prostate cancer, regardless of their race, according to a University of North Carolina study published in the current issue of the journal Cancer.
Located in Vital Signs / Archives / Vital Signs - July 31, 2009
UCRF Strategic Plan Moves to Implementation
The University Cancer Research Fund (UCRF) is a nation-leading investment in research to reduce the burden of cancer in North Carolina – our state’s leading cause of death. Established in August 2007 by the State of North Carolina, the fund supports cancer research at the UNC Lineberger Comprehensive Cancer Center and UNC Hospitals.
Located in Vital Signs / 2010 / Vital Signs - March 25, 2010
Physician trust, early screening reduces disparities for prostate cancer
Men who have a regular, ongoing relationship with a health care provider are more likely to receive prostate cancer screening and less likely to be diagnosed with advanced prostate cancer, regardless of their race, according to a University of North Carolina study published in the current issue of the journal Cancer.
Located in Vital Signs / 2009 / Vital Signs - July 31, 2009
UNC scientists tackle viral mysteries
Scientists know that some cancers are triggered by viruses, which take over cellular systems and cause uncontrolled cell growth. Doctors – and patients who get shingles late in life – have also known for many years that some viruses, particularly the herpes virus, can lie dormant in a person’s cells for long periods of time and then reactivate, causing disease. These viruses also cause significant disease in immunosuppressed people and those living with HIV/AIDS.
Located in Vital Signs / 2009 / Vital Signs - July 2, 2009
Ewend honored by Johns Hopkins University School of Medicine
Matthew G. Ewend, M.D., director of the UNC Lineberger Comprehensive Cancer Center program in neuro-oncology, received the Alumni Achievement Award from the Johns Hopkins University School of Medicine’s Department of Neurosurgery.
Located in Vital Signs / Archives / Vital Signs - July 2, 2009
Mission Hospital, UNC Health Care forge agreement for cancer care, research
Mission Hospital and UNC Health Care announced Aug. 19 that they have signed an affiliation agreement for cancer care and research, with the overall goal of enhancing the quality of care for cancer patients in western North Carolina, including providing access to new therapies and innovative research programs under development at UNC Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital.
Located in Vital Signs / Archives / Vital Signs - August 21, 2009
Kay Yow Cancer Fund awards $1 million research grant to UNC Lineberger
The Kay Yow Cancer Fund®, in partnership with The V Foundation for Cancer Research, has awarded a $1 million women’s cancer research grant to UNC Lineberger to evaluate the impact of physical activity among breast cancer survivors.
Located in Vital Signs / 2014 / March 6
UNC Lineberger Presents 2009 Oncology Nursing and Service Awards
UNC Lineberger Comprehensive Cancer Center recognized four staff members with the 2009 Oncology Nursing Excellence Awards and the Clinical Services Excellence Awards.
Located in Vital Signs / Archives / Vital Signs - Nov. 12, 2009
Please join us in celebrating the New Face of Cancer Care
The N.C. Cancer Hospital is now open and is serving the people of North Carolina!
Located in Vital Signs / Archives / Vital Signs - Sept. 3, 2009
DeSimone accepts adjunct appointment at Memorial Sloan-Kettering Cancer Center
Joseph DeSimone, PhD, a member of UNC Lineberger Comprehensive Cancer Center, has been appointed as an adjunct member at New York’s Memorial Sloan-Kettering Cancer Center’s Cancer Nanocenter. The appointment is part of a strategic alliance aimed at building Sloan-Kettering’s capabilities in nanomedicine and broadening the geographic base of DeSimone’s pioneering work based in North Carolina.
Located in Vital Signs / 2010 / Vital Signs - June 17, 2010